Founded with a mission to revolutionize bioengineering, ATUM leverages advanced machine learning and GPS technology to optimize biological systems. The company offers a suite of biotechnology services including codon optimization, recombinant protein production, antibody humanization and engineering, and cell line development. ATUM focuses on providing tailored solutions to life sciences researchers, aiming to accelerate their path to market and enhance the efficiency of their experimental processes.
ATUM's notable affiliations include collaborations with leading research institutions and biotech companies. The company has attracted investment from prominent venture capital firms specializing in life sciences. Key achievements include the successful deployment of their GPS® technology platform, which integrates design of experiments (DoE) with machine learning to deliver optimized bioengineering solutions. Overall, ATUM has made a significant impact by advancing research capabilities and expediting the development of innovative biotechnological applications.
